Effect of Fenretinide on Ovarian Carcinoma Occurrence
- 1 July 2002
- journal article
- clinical trial
- Published by Elsevier in Gynecologic Oncology
- Vol. 86 (1), 24-27
- https://doi.org/10.1006/gyno.2002.6663
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Effects of Retinoids on Cancerous Phenotype and Apoptosis in Organotypic Cultures of Ovarian CarcinomaJNCI Journal of the National Cancer Institute, 2001
- Randomized Trial of Fenretinide to Prevent Second Breast Malignancy in Women With Early Breast CancerJNCI Journal of the National Cancer Institute, 1999
- Growth-inhibitory effects of the synthetic retinoid CD437 against ovarian carcinoma models in vitro and in vivoCancer Chemotherapy and Pharmacology, 1998
- Retinoic Acid Receptor β Expression and Growth Inhibition of Gynecologic Cancer Cells by the Synthetic Retinoid N-(4-Hydroxyphenyl) RetinamideJNCI Journal of the National Cancer Institute, 1998
- Chemoprevention Trial of Contralateral Breast Cancer with Fenretinide. Rationale, Design, Methodology, Organization, Data Management, Statistics and AccrualTumori Journal, 1997
- Can Fenretinide Protect Women Against Ovarian Cancer?JNCI Journal of the National Cancer Institute, 1995
- Fenretinide (4-HPR) in chemoprevention of oral leukoplakiaJournal of Cellular Biochemistry, 1993
- Prevention of Skin Cancer in Xeroderma Pigmentosum with the Use of Oral IsotretinoinNew England Journal of Medicine, 1988
- AnnouncementGynecologic Oncology, 1986
- Effects of vitamin A and its analogs (retinoids) on normal and neoplastic cellsBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 1980